During the past decade, Monash Cancer Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Monash Cancer Centre" are "Breast Cancer" (1 trials), "Carcinoma, Non-squamous Non-small-cell Lung" (1 trials), "Carcinoma, Squamous Cell, Non-small-cell Lung" (1 trials), "Endometrial Cancer" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "Monash Cancer Centre" in a lesser frequency.

Most popular intervention types in "Monash Cancer Centre" are "Drug" (3 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Olaparib" (2 trials), "Pembrolizumab" (2 trials), "CYH33" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Monash Cancer Centre" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Monash Cancer Centre". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Monash Cancer Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Monash Cancer Centre, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".